Macroview Investment Management’s Novo Nordisk NVO Stock Holding History

Macroview Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-37	Closed	-$4.41K	–	385
2024 Q3	$4.41K	Hold	37	–	–	﹤0.01%	387
2024 Q2	$5.28K	Sell	37 -23	-38%	-$3.05K	0.01%	364
2024 Q1	$7.7K	Hold	60	–	–	0.01%	325
2023 Q4	$6.21K	Sell	60 -60	-50%	-$5.93K	0.01%	368
2023 Q3	$10.9K	Buy	120 +60	+100%	+$5.29K	0.01%	236
2023 Q2	$4.86K	Buy	+60	New	+$4.9K	0.01%	348
2015 Q1	–	Sell	-40	Closed	-$1K	–	208
2014 Q4	$1K	Hold	40	–	–	﹤0.01%	171
2014 Q3	$1K	Buy	+40	New	+$920	﹤0.01%	179
2013 Q3	–	Sell	-750	Closed	-$12K	–	253
2013 Q2	$12K	Buy	+750	New	+$12.5K	0.01%	72

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Macroview Investment Management's NVO Position: Q4 2024 in Review

Macroview Investment Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 37 shares — an estimated $4.41K sold.

Macroview Investment Management first reported a position in NVO in Q2 2013 and held it in 9 quarters. The position peaked at $12K in Q2 2013. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

Macroview Investment Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
Macroview Investment Management sold 37 Novo Nordisk shares in Q4 2024, an estimated $4.41K.
Macroview Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 9 quarters.
Macroview Investment Management's Novo Nordisk position peaked at $12K in Q2 2013.
1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.